Associations - BCL6 rearrangement

BIOMARKER:

BCL6 rearrangement

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

BCL6 rearrangement BCL6 rearrangement	Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma	lisocabtagene maraleucel Sensitive: C2 – Inclusion Criteria lisocabtagene maraleucel Sensitive : C2
BCL6 rearrangement BCL6 rearrangement	Lymphoma Lymphoma	multiplex silenced CAR-T therapy Resistant: C3 – Early Trials multiplex silenced CAR-T therapy Resistant : C3
BCL6 rearrangement BCL6 rearrangement	Mediastinal B Cell Lymphoma Mediastinal B Cell Lymphoma	rituximab Sensitive: C3 – Early Trials rituximab Sensitive : C3